Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: AIDS Behav. 2021 Sep 25;26(3):947–962. doi: 10.1007/s10461-021-03450-2

Table III.

Unadjusted logistic regression models and adjusted multilevel adjusted logistic regression model for VS

Model 1: MHDI Model 2: SVI
Unadjusted OR (95% CI) Wald test z value P-value Adjusted OR (95% CI) Wald test z value P-value Adjusted OR (95% CI) Wald test z value P-value
Age at time of ART initiation (IQR) 1.14 (1.02, 1.26) 2.41 0.02 1.20 (1.07, 1.34) 3.19 0.001 1.20 (1.08, 1.34) 3.22 0.001
Age Category (years)
 <30 Ref Ref Ref
 30–40 1.19 (0.93, 1.52) 1.35 0.18
 40–50 1.23 (0.92, 1.63) 1.42 0.16
 >50 1.54 (1.04, 2.29) 2.13 0.03
Race
 White Ref Ref Ref Ref Ref Ref Ref Ref Ref
 Black 0.87 (0.67, 1.17) −0.86 0.39 0.90 (0.67, 1.20) −0.72 0.47 0.89 (0.67, 1.20) −0.75 0.45
 Mixed/Unknown 0.98 (0.77, 1.24) −0.17 0.86 0.96 (0.74, 1.23) −0.36 0.72 0.96 (0.74, 1.23) −0.35 0.73
Education
 Less than 8 Years Ref Ref Ref Ref Ref Ref Ref Ref Ref
 More than 8 Years 1.42 (1.15, 1.75) 3.28 0.001 1.30 (1.03, 1.65) 2.21 0.03 1.31 (1.04, 1.66) 2.27 0.02
 Unknown -- -- --
Gender and exposure risk
 Cisgender women Ref Ref Ref Ref Ref Ref Ref Ref Ref
 TGW 1.19 (0.65, 2.17) 0.55 0.58 1.24 (0.66, 2.33) 0.66 0.51 1.26 (0.67, 2.37) 0.70 0.48
 Cis-MSM 1.72 (1.33, 2.21) 4.18 <0.0001 1.57 (1.18, 2.08) 3.12 0.002 1.58 (1.19, 2.09) 3.16 0.002
 Heterosexual cisgender men 1.39 (1.05, 1.85) 2.30 0.02 1.36 (1.01, 1.83) 2.02 0.04 1.37 (1.01, 1.84) 2.05 0.04
 Cisgender men: other and unknown 0.98 (0.64, 1.49) −0.11 0.91 1.08 (0.68, 1.71) 0.33 0.74 1.07 (0.68, 1.70) 0.30 0.76
Pre-treatment CD4 count (cells/mm3)
 <200 Ref Ref Ref Ref Ref Ref Ref Ref Ref
 200–350 1.38 (1.04, 1.82) 2.32 0.03 1.23 (0.91, 1.67) 1.34 0.18 1.23 (0.91, 1.67) 1.35 0.18
 350–500 1.42 (1.00, 2.03) 1.94 0.05 1.28 (0.86, 1.90) 1.23 0.22 1.27 (0.85, 1.88) 1.17 0.24
 >500 1.44 (0.98, 2.11) 1.86 0.06 1.33 (0.86, 2.05) 1.29 0.20 1.34 (0.87, 2.06) 1.31 0.19
 Unknown 0.45 (0.34, 0.61) −5.29 <0.0001 0.55 (0.35, 0.84) −2.76 0.006 0.54 (0.35, 0.84) −2.77 0.006
Pre-treatment viral load (copies/mL)
 <100,000 Ref Ref Ref Ref Ref Ref Ref Ref Ref
 ≥100,000 0.69 (0.54, 0.88) −3.00 0.003 0.74 (0.56, 0.97) −2.19 0.03 0.74 (0.56, 0.97) −2.17 0.03
 Unknown 0.42 (0.32, 0.54) −6.44 <0.0001 0.78 (0.52, 1.18) −1.18 0.24 0.78 (0.52 1.17) −1.18 0.24
Opportunistic illness
 No Ref Ref Ref
 Yes 0.99 (0.79, 1.25) −0.08 0.94
TB
 No Ref Ref Ref Ref Ref Ref Ref Ref Ref
 Yes 1.05 (0.79, 1.40) 0.32 0.75 1.20 (0.87, 1.65) 1.13 0.26 1.20 (0.87, 1.64) 1.18 0.26
ART initiation year
 2000–2004 Ref Ref Ref Ref Ref Ref Ref Ref Ref
 2005– 2008 2.15 (1.57, 2.95) 4.75 <0.0001 1.90 (1.36, 2.64) 3.79 <0.0001 1.89 (1.36, 2.63) 3.75 <0.001
 2009– 2012 3.43 (2.49, 4.73) 7.52 <0.0001 2.89 (2.06, 4.04) 6.17 <0.0001 2.87 (2.05, 4.02) 6.13 <0.001
 2013– 2016 2.47 (1.82, 3.33) 5.86 <0.0001 2.05 (1.47, 2.86) 4.20 <0.0001 2.03 (1.45, 2.84) 4.15 <0.001
MHDI (IQR) 0.72 (0.27, 1.87) −0.68 0.49
MHDI category
 High- Very High Ref Ref Ref Ref Ref Ref
 Medium 0.95 (0.74, 1.21) −0.43 0.67 1.06 (0.81, 1.39) 0.41 0.68
 Very low- low 0.98 (0.76, 1.27) −0.15 0.88 1.12 (0.84, 1.50) 0.77 0.44
SVI median (IQR) 1.71 (0.62, 4.61) 1.06 0.29
SVI category
 Very Low- Low Ref Ref Ref Ref Ref Ref
 Medium 0.99 (0.79, 1.25) −0.06 0.95 1.12 (0.87, 1.43) 0.85 0.39
 High- Very High 1.05 (0.77, 1.44) 0.32 0.75 1.21 (0.85, 1.71) 1.05 0.29
Intraclass Correlation Coefficient (ICC) 0.005 0.004